Vitality Watch

Dossier rss preclinical 29-sep-2026
Animal model, organoid, or cell-culture result — not yet human

Dietary CoQ10 Ameliorates Age‐Related Megakaryocyte Dysfunction via COPS3‐Mediated Activation of Autophagy

Key claim: Dietary CoQ10 ameliorates age-related megakaryocyte dysfunction through COPS3-mediated activation of autophagy.

Abstract

Aging Cell, Volume 25, Issue 10, October 2026.

Why this matters

CoQ10 is a long-standing supplement with weak healthspan evidence; this paper proposes a concrete molecular route — COPS3-dependent autophagy activation in megakaryocytes — through which dietary CoQ10 might normalize an aged hematopoietic lineage and reduce platelet hyperreactivity. It is a preclinical mouse study, so the gap between ‘autophagy restored in aged mouse megakaryocytes’ and ‘CoQ10 reduces thrombotic risk in older humans’ remains wide, but it gives the autophagy page a new upstream node (COPS3) and extends the autophagy-inducer list beyond spermidine/rapamycin/fasting.

Source

Link

Briefing card

Dietary CoQ10 Ameliorates Age‐Related Megakaryocyte Dysfunction via COPS3‐Mediated Activation of Autophagy
Stage: preclinical · rss · 29-sep-2026

If you take CoQ10, this adds a mouse-level mechanism (autophagy via COPS3) but no new human outcome data on platelets, hemostasis, or aging.

Dietary CoQ10 ameliorates age-related megakaryocyte dysfunction through COPS3-mediated activation of autophagy.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: url:https://onlinelibrary.wiley.com/doi/10.1111/acel.70726?af=R

build build 880 · 2bcef25 · 2026-11-18